Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib vs Dacarbazine in c-Kit Mutated Melanoma
NCT01280565Phase 3Terminated
- Sponsor
- AB Science
- Start
- Jan 2011
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of masitinib in melanoma, sponsored by AB Science. Started Jan 2011; status: terminated.
02
Drugs
masitinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01280565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280565.